Trials registries are a relatively new phenomenon and are there to ensure that a complete view of research is accessible to all. Yet, half off all trial results go unreported.

The talk will discuss the important of registries the evidence in the registry that matters and discuss how the CEBM and EBM Datalab are working with the WHO to improve clinical trial transparency

Professor Carl Heneghan is an advisor to the World Health Organization’s International Clinical; Trial Registry Platform and co-founder of AllTrials.